Flurbiprofen Sodium eent and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Flurbiprofen Sodium eent and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: flurbiprofen ophthalmic
Brand name: Ocufen
Synonyms: Flurbiprofen ophthalmic
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Flurbiprofen Sodium eent-Insulin glargine, recombinant Subcutaneous
- Flurbiprofen Sodium eent-Insulin glulisine
- Flurbiprofen Sodium eent-Insulin Glulisine (Cartridges and Pens)
- Flurbiprofen Sodium eent-Insulin Glulisine (Vials)
- Flurbiprofen Sodium eent-Insulin glulisine Subcutaneous
- Flurbiprofen Sodium eent-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Flurbiprofen Tablets
- Insulin glargine and lixisenatide Subcutaneous-Flurosyn
- Insulin glargine and lixisenatide Subcutaneous-Flushield injection
- Insulin glargine and lixisenatide Subcutaneous-Flutabs
- Insulin glargine and lixisenatide Subcutaneous-Flutamide
- Insulin glargine and lixisenatide Subcutaneous-Fluticasone